Forte Biosciences, Inc.

Healthcare · Biotechnology · United States

Last price 76.99 USD (Aug 26, 2026, 4:00 PM EDT) · Market cap 1.94B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Forte Biosciences, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for autoimmune and autoimmune-related diseases. The company offers products, such as its lead product candidate FB102, a proprietary molecule with applications for celiac disease, vitiligo, and alopecia areata; and services, including the clinical development and management of its Phase 2 clinical trials. Forte Biosciences, Inc. was incorporated in 2007 and is based in Dallas, Texas. As of August 27, 2026, Forte Biosciences, Inc. operates as a subsidiary ...